Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T13:45:55.343Z.
Calculation as of: 2026-10-06T13:45:55.343Z.
Quote observation: 2026-10-06T13:37:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9652a66304d340e7e9e30300cf06612173ff3018e86bcae2610861655b1402c2
PEG RATIO
N/A
Park Ha Biological Technology Co., Ltd. Ordinary Shares
Market Cap
$1.76M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) | $1.76M | N/A |
| Innovation Beverage Group Limited (IBG)vs › | $1.71M | N/A |
| IP Strategy Holdings, Inc. (IPST)vs › | $1.65M | N/A |
| Instinct Bio Technical Co. Holdings Inc. (BIOT)vs › | $1.55M | N/A |
| Golden Sun Education Group Limited (GSUN)vs › | $2.02M | N/A |
| AMASS Brands Inc. Common Stock (AMSS)vs › | $1.44M | N/A |
| Agape ATP Corporation (ATPC)vs › | $2.13M | N/A |
| Maison Solutions Inc. Class A Common Stock (MSS)vs › | $1.31M | N/A |
| Fitness Champs Holdings Limited (FCHL)vs › | $1.19M | N/A |
| Chanson International Holding (CHSN)vs › | $2.37M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
